7

Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

Download PDF Report

Upload
others
View
4
Download
0

Embed Size (px)

Citation preview

Page 1: Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

Page 2: Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

Page 3: Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

Page 4: Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

Page 5: Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

Page 6: Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

Page 7: Columbia University in the City of New York...e.g. haptens Factors affecting immunogenicity: —protein>polysaccharides>>NAs, lipids —T cells will only bind protein Ags 1) foreigness:

$Validation for Immunogenicity Testing of …\\16645dftR1.doc 4/20/16 Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products Guidance for Industry$

Validation for Immunogenicity Testing of …\\16645dftR1.doc 4/20/16 Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products Guidance for Industry

Documents

2 antigens, immunogens, epitopes, and haptens

2 antigens, immunogens, epitopes, and haptens

Documents

Modulating Linker Composition of Haptens Resulted in

Modulating Linker Composition of Haptens Resulted in

Documents

Toward de novo design of immune silent protein and peptide ... · • Heat stable, 90 aa mini-protein • Wide range of immune-oncology applications • No immunogenicity observed

Toward de novo design of immune silent protein and peptide ... · • Heat stable, 90 aa mini-protein • Wide range of immune-oncology applications • No immunogenicity observed

Documents

Protein Therapeutics Immunogenicity Stephen Lynn 11-16-11 CHEM645 0

Protein Therapeutics Immunogenicity Stephen Lynn 11-16-11 CHEM645 0

Documents

Immunogenicity of Biopharmaceuticals: Potential Impact … · Immunogenicity of Biopharmaceuticals: Potential Impact of Protein Characteristics Holly W. Smith Eli Lilly and Company,

Immunogenicity of Biopharmaceuticals: Potential Impact … · Immunogenicity of Biopharmaceuticals: Potential Impact of Protein Characteristics Holly W. Smith Eli Lilly and Company,

Documents

2006 Baculovirus Surface Display of SARS Coronavirus (SARS-CoV) Spike Protein and Immunogenicity of the Displayed Protei

2006 Baculovirus Surface Display of SARS Coronavirus (SARS-CoV) Spike Protein and Immunogenicity of the Displayed Protei

Documents

Improving the cellular immunogenicity of recombinant ... · Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein

Improving the cellular immunogenicity of recombinant ... · Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein

Documents

IMMUNOGENICITY OF RECOMBINANT HS ABA392 PROTEIN …studentsrepo.um.edu.my/9364/2/Rita_Devi_Velappan_@_Morthy_-_Thesis.pdfimmunogenicity of recombinant hs aba392 protein vaccine against

IMMUNOGENICITY OF RECOMBINANT HS ABA392 PROTEIN …studentsrepo.um.edu.my/9364/2/Rita_Devi_Velappan_@_Morthy_-_Thesis.pdfimmunogenicity of recombinant hs aba392 protein vaccine against

Documents

Eﬀects of Protein Conformation, Apparent Solubility, and ... · protein aggregates can compromise drug eﬃcacy by decreasing potency and/or by increasing product immunogenicity

Eﬀects of Protein Conformation, Apparent Solubility, and ... · protein aggregates can compromise drug eﬃcacy by decreasing potency and/or by increasing product immunogenicity

Documents

EpiVax Host Cell Protein Immunogenicity tool: CHOPPI May 13 2014, Dubrovnik

EpiVax Host Cell Protein Immunogenicity tool: CHOPPI May 13 2014, Dubrovnik

Science

T-Cell Dependent Immunogenicity of Protein Therapeutics Pre … · 2020. 7. 12. · new generic drugs that enter the generic development pathway. For peptide or protein-based drugs,

T-Cell Dependent Immunogenicity of Protein Therapeutics Pre … · 2020. 7. 12. · new generic drugs that enter the generic development pathway. For peptide or protein-based drugs,

Documents

2018 PATHOGENICITY, IMMUNOGENICITY, PROTECTION EFFICACY, AND SPIKE PROTEIN GENE SEQUENCE OF A HIGH-PASSAGE TURKEY CORONA

2018 PATHOGENICITY, IMMUNOGENICITY, PROTECTION EFFICACY, AND SPIKE PROTEIN GENE SEQUENCE OF A HIGH-PASSAGE TURKEY CORONA

Documents

Validation for Immunogenicity Testing of Therapeutic Protein

Validation for Immunogenicity Testing of Therapeutic Protein

Documents

1998 Characterization of the expression and immunogenicity of the ns4b protein of human coronavirus 229E

1998 Characterization of the expression and immunogenicity of the ns4b protein of human coronavirus 229E

Documents

Zwitterionic gel encapsulation promotes protein stability ... · Advances in protein therapy are hindered by the poor stability, inadequate pharmacokinetic (PK) profiles, and immunogenicity

Zwitterionic gel encapsulation promotes protein stability ... · Advances in protein therapy are hindered by the poor stability, inadequate pharmacokinetic (PK) profiles, and immunogenicity

Documents

Effects of Silicone-Water Interfaces on Protein Structure ... · Effects of Silicone-Water Interfaces on Protein Structure, Aggregation, Particle Formation and Immunogenicity John

Effects of Silicone-Water Interfaces on Protein Structure ... · Effects of Silicone-Water Interfaces on Protein Structure, Aggregation, Particle Formation and Immunogenicity John

Documents

Validation for Immunogenicity Testing of … for Immunogenicity Testing of Therapeutic Protein Products ... 1 Assay Development and Validation for Immunogenicity Testing of 2 .

Validation for Immunogenicity Testing of … for Immunogenicity Testing of Therapeutic Protein Products ... 1 Assay Development and Validation for Immunogenicity Testing of 2 .

Documents

Cloning, Expression, and Immunogenicity Analysis of the ...3.4. Expression of the Recombinant Protein The protein expression was observed in expression host BL21 (DE3). A distinct

Cloning, Expression, and Immunogenicity Analysis of the ...3.4. Expression of the Recombinant Protein The protein expression was observed in expression host BL21 (DE3). A distinct

Documents

PREPARATION, CHARACTERIZATION, AND ......PREPARATION, CHARACTERIZATION, AND IMMUNOGENICITY OF HAEMOPHILUS INFLUENZAE TYPE b POLYSACCHARIDE- PROTEIN CONJUGATES BY …

PREPARATION, CHARACTERIZATION, AND ......PREPARATION, CHARACTERIZATION, AND IMMUNOGENICITY OF HAEMOPHILUS INFLUENZAE TYPE b POLYSACCHARIDE- PROTEIN CONJUGATES BY …

Documents

A novel vaccine approach for Neisseria meningitidis; heat shock protein-antigen complexes (HspC) demonstrate cross-strain immunogenicity Chris Bailey*,

A novel vaccine approach for Neisseria meningitidis; heat shock protein-antigen complexes (HspC) demonstrate cross-strain immunogenicity Chris Bailey*,

Documents

Antigens Where we’re going- Immunogenicity vs antigenicity What makes for a good immunogen Haptens Pattern recognition receptors

Antigens Where we’re going- Immunogenicity vs antigenicity What makes for a good immunogen Haptens Pattern recognition receptors

Documents

EpiVax ISPRI: Next Generation Immunogenicity Screening and Protein Re-engineering

EpiVax ISPRI: Next Generation Immunogenicity Screening and Protein Re-engineering

Technology

Managing Immunogenicity Using Quantitative Systems Pharmacology · 2020. 6. 8. · Immunogenicity (IG) is defined by the FDA as the propensity of the therapeutic protein to generate

Managing Immunogenicity Using Quantitative Systems Pharmacology · 2020. 6. 8. · Immunogenicity (IG) is defined by the FDA as the propensity of the therapeutic protein to generate

Documents

Immunogenicity Assessment for Therapeutic Protein Products · PDF fileGuidance for Industry . Immunogenicity Assessment for Therapeutic Protein Products . U.S. Department of Health

Immunogenicity Assessment for Therapeutic Protein Products · PDF fileGuidance for Industry . Immunogenicity Assessment for Therapeutic Protein Products . U.S. Department of Health

Documents

Immunogenicity of Protein Therapeutics: time to get personal?

Immunogenicity of Protein Therapeutics: time to get personal?

Documents

Antigens & Immunogen. Immunogens Immunogenicity Antigenicity Allergen Allergoid Mitogen Super antigen Hapten (Hapten-carrier) Haptens are partial antigens

Antigens & Immunogen. Immunogens Immunogenicity Antigenicity Allergen Allergoid Mitogen Super antigen Hapten (Hapten-carrier) Haptens are partial antigens

Documents

Immunogenicity 2016

Immunogenicity 2016

Health & Medicine

Noncompetitive Immunoassay Detection System for Haptens on ... › b341 › e224d5f9d01a... · Noncompetitive Immunoassay Detection System for Haptens on the Basis of Antimetatype

Noncompetitive Immunoassay Detection System for Haptens on ... › b341 › e224d5f9d01a... · Noncompetitive Immunoassay Detection System for Haptens on the Basis of Antimetatype

Documents

Immunogenicity of Therapeutic Proteins - NIHS · Causes of Immunogenicity • Sequence differences between therapeutic protein and endogenous protein • Structural alterations –

Immunogenicity of Therapeutic Proteins - NIHS · Causes of Immunogenicity • Sequence differences between therapeutic protein and endogenous protein • Structural alterations –

Documents